Suboxone comes in various formats. It is a hexagonal (six-sided) orange pill that constitutes a partial opioid medication employed for addiction treatment.
The pill’s potency is imprinted on its surface, using a labelling system akin to Suboxone strips, denoted as N2, N4, N8, and N12, corresponding to doses of 2mg, 4mg, 8mg, and 12mg.
The generic version of Suboxone is a circular orange pill available solely in an 8mg strength. The 8mg dose of generic Suboxone pills is marked with the imprint AN 415.
Different Suboxone Pills
Various forms of Suboxone pills are available to address opioid use disorder (OUD), employing a combination of buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist.
The medications that utilize buprenorphine/naloxone for treating opioid addiction encompass Subutex, Sublocade, Bunavail, and Zubsolv. Subutex takes the form of a white, oval buprenorphine-only pill. Sublocade is administered as a monthly abdominal injection.
Further information about Suboxone shots can be found in the resource “What You Should Know About Suboxone Shots.” Bunavail is a buccal film that contains buprenorphine/naloxone.
Zubsolv presents itself as a sublingual pill also consisting of buprenorphine/naloxone. Suboxone, available as both a sublingual film and tablet, is produced in an orange hue.
Suboxone pills were introduced prior to the advent of Suboxone films in 2002. Notably, the potential for misuse is notably higher with Suboxone tablets compared to Suboxone films.
Should the buprenorphine from Suboxone tablets enter the system through intravenous or intranasal means, it triggers full opioid effects at the receptor site, leading to intoxication and a substantial risk of overdose.
Orange Generic Suboxone Pill
The generic version of Suboxone, produced by Amneal Pharmaceuticals, takes the form of a round orange pill imprinted with the alphanumeric code AN 415. These generic Suboxone pills are exclusively available in 8 mg dosages.
The composition of buprenorphine and naloxone in these pills follows a ratio of 4:1, with 8 mg of buprenorphine and 2 mg of naloxone. The distinctive feature of the 8 mg Suboxone dose is the AN 415 marking present on the circular orange tablet.
AN 415 Suboxone
Suboxone is characterized as a prolonged-acting medication that does not induce the dopamine surge responsible for perpetuating the desire for opioids. Moreover, it boasts an extended half-life, indicating the time required for half of the medication to exit the body.
Upon ingestion, the body begins metabolizing the medication, similar to any foreign substance. Buprenorphine exhibits a half-life exceeding 30 hours, enabling its effects to persist for up to 2 days, effectively curbing opioid cravings.
The ‘ceiling effect’ and partial agonist nature of buprenorphine mitigate the development of tolerance to the drug’s effects. For more information on buprenorphine’s threshold, refer to “Can Suboxone Lead to Addiction?” Suboxone effectively combats cravings, terminates withdrawal symptoms, and alleviates mood disturbances.
Although certain patients prescribed high doses of Suboxone have experienced pupil constriction, the drug’s beneficial aspects such as pain relief, withdrawal prevention, and mood enhancement outweigh any drawbacks.
Gradually tapering off Suboxone can lead to withdrawal, potential relapse, and overdose. The misuse or overdose of Suboxone can similarly result in withdrawal, relapse, and overdose.
Individuals in recovery who are exposed to environments that do not support sobriety are at a heightened risk of succumbing to withdrawal, relapse, and overdose.
In order to reap the benefits of effective medication-assisted treatment, it is imperative to maintain a stable mental state and supportive surroundings. With these stable psychosocial factors in place, a structured tapering off Suboxone becomes a feasible option.
It is essential to collaboratively devise a tapering plan with a medical professional, as self-directed adjustments to dosage are not advisable.
Medication-assisted treatment (MAT) constitutes a rehabilitative strategy that combines prescription medication, often accompanied by behavioural therapy and social reinforcement.
Much like how the effectiveness of Suboxone varies from person to person, patients engaged in 12-step programs for addiction treatment, some individuals may rely on medication-assisted treatment indefinitely, while others could successfully taper their doses and transition away from Suboxone’s assistance.
Read Also: Butilhioscina Paracetamol | Uses, Side Effects, Interactions, Dosage
Generic Suboxone Pills
The impacts of Suboxone sublingual pills and their generic counterparts are indistinguishable. The combination of buprenorphine and naloxone serves to bridge the gap in opioid dependence, enabling patients to regain functionality and resume their normal lives.
Suboxone functions as a partial opioid agonist targeting the mu receptor, counteracting the development of tolerance to the medication. While it diminishes withdrawal symptoms and cravings, it’s important to note that physical dependence on Suboxone is possible.
The team at Confidant possesses a profound understanding of the advantages of medication-assisted treatment. Our team of fully licensed professionals is here to support you.
Should you have inquiries regarding medication-assisted treatment, Suboxone films, generic Suboxone pills, Suboxone tapering, or any related topics, feel free to reach out to us today.
Advantages of the 8mg Round Orange Suboxone Pill
The 8mg round orange Suboxone pill offers several benefits in the context of opioid addiction treatment and recovery. Here are some of its advantages:
- Effective Dosing: The 8mg dose of Suboxone provides a substantial amount of buprenorphine, the partial opioid agonist. This dose can effectively alleviate withdrawal symptoms and reduce cravings, helping individuals transition away from more potent opioids.
- Withdrawal Relief: The 8mg Suboxone pill is designed to help manage and minimize the discomfort of opioid withdrawal symptoms. This can include nausea, muscle aches, anxiety, and other physical and psychological symptoms associated with quitting opioids.
- Reduced Cravings: Buprenorphine’s partial agonist properties work to satisfy the brain’s opioid receptors to a certain extent, reducing the intense cravings that drive opioid misuse and addiction.
- Safety Mechanism: The inclusion of naloxone in the formulation adds a safety feature. If someone attempts to misuse Suboxone by injecting it, the naloxone component can trigger withdrawal symptoms, acting as a deterrent against misuse.
- Tolerance Management: Buprenorphine’s ceiling effect helps manage tolerance development. This means that even if someone takes more of the medication, the opioid effects plateau, reducing the risk of escalating doses.
- Long-Lasting Effects: The prolonged half-life of buprenorphine, more than 30 hours, means that the effects of the 8mg Suboxone pill can last for up to two days. This provides continuous relief from withdrawal symptoms and cravings.
- Structured Treatment: The 8mg dose offers a standardized treatment option, allowing healthcare professionals to establish consistent and manageable dosing regimens.
- Medication-Assisted Treatment (MAT): The 8mg Suboxone pill is a central component of Medication Assisted Treatment programs, which combine medication with behavioural therapy and support to enhance the chances of sustained recovery.
- Reduced Risk of Overdose: By providing a controlled dose of buprenorphine and naloxone, the 8mg Suboxone pill helps reduce the risk of accidental overdose that can occur with illicit opioid use.
Conclusion
The 8mg round orange Suboxone pill plays a pivotal role in the landscape of opioid addiction treatment. With its combination of buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, this medication offers a range of valuable benefits for individuals on the path to recovery.
By providing an effective 8mg dose of buprenorphine, the pill serves as a powerful tool to manage withdrawal symptoms and cravings associated with opioid dependence.
The prolonged effects of buprenorphine’s half-life, lasting up to two days, ensure sustained relief, allowing individuals to regain control over their lives without the constant grip of cravings.
